We uncovered the intricate interplay between central nervous system inflammationand cognitive dysfunction demonstrating an inflammatory process in both central and peripheral regions in diabetic mice
Among the drug-induced DNA lesions, abasic (apurinic/apyrimidinic, AP) sites are one of the most common types in cells, and can lead to more deleterious lesions such as DNA strand breaks [4, 5]
He added: If scientists are able to further demonstrate that this is working in patients with Alzheimers disease phase 3 trials, and the FDA approves it for Alzheimers, this drug could then be immediately available. Two independent phase 3 trials are already underway, with findings due at the end of 2025.
P., et al., The Effect of Body Mass Index on GlucagonLike Peptide Receptor Gene Expression in the Post Mortem Brain From Individuals With Mood and Psychotic Disorders, European Neuropsychopharmacology 29, no
KEY TAKEAWAYS Weight regain while on GLP-1 medications is more common than most people realize Hair loss from weight loss medications is usually related to nutrient deficiencies, not the medication itself Leptin dysfunction involves both hormone levels and signaling pathways throughout the body Hypoglycemia after meals often indicates complex metabolic issues that require specialized testing Starting elderly patients on GLP-1s requires careful monitoring of nutrition, blood pressure, and side effects Mechanical eating differs from intuitive eating and remains important even when medications are working Annual weight loss rates of 10% or higher indicate medications are still effective NOTABLE QUOTE "It is not uncommon to see the weight go up while on these meds, contrary to what people think
